nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Dactinomycin—testicular cancer	0.126	0.193	CbGbCtD
Lomitapide—CYP3A4—Ifosfamide—testicular cancer	0.089	0.137	CbGbCtD
Lomitapide—ABCB1—Vinblastine—testicular cancer	0.0788	0.121	CbGbCtD
Lomitapide—ABCB1—Cisplatin—testicular cancer	0.0723	0.111	CbGbCtD
Lomitapide—ABCB1—Etoposide—testicular cancer	0.071	0.109	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—testicular cancer	0.0484	0.0744	CbGbCtD
Lomitapide—CYP3A4—Vinblastine—testicular cancer	0.0472	0.0725	CbGbCtD
Lomitapide—ABCB1—Methotrexate—testicular cancer	0.0469	0.0721	CbGbCtD
Lomitapide—CYP3A4—Etoposide—testicular cancer	0.0425	0.0654	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—testicular cancer	0.029	0.0446	CbGbCtD
Lomitapide—MTTP—embryo—testicular cancer	0.0154	0.418	CbGeAlD
Lomitapide—MTTP—female gonad—testicular cancer	0.00851	0.23	CbGeAlD
Lomitapide—MTTP—testis—testicular cancer	0.00755	0.204	CbGeAlD
Lomitapide—ABCB1—embryo—testicular cancer	0.00136	0.0369	CbGeAlD
Lomitapide—ABCB1—seminal vesicle—testicular cancer	0.00128	0.0346	CbGeAlD
Lomitapide—ABCB1—gonad—testicular cancer	0.000925	0.025	CbGeAlD
Lomitapide—ABCB1—female gonad—testicular cancer	0.000751	0.0203	CbGeAlD
Lomitapide—Back pain—Etoposide—testicular cancer	0.00073	0.00234	CcSEcCtD
Lomitapide—Muscle spasms—Etoposide—testicular cancer	0.000725	0.00232	CcSEcCtD
Lomitapide—Body temperature increased—Bleomycin—testicular cancer	0.000721	0.00231	CcSEcCtD
Lomitapide—Dizziness—Vinblastine—testicular cancer	0.000714	0.00229	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00071	0.00228	CcSEcCtD
Lomitapide—Pain in extremity—Epirubicin—testicular cancer	0.000702	0.00225	CcSEcCtD
Lomitapide—Myalgia—Cisplatin—testicular cancer	0.000701	0.00225	CcSEcCtD
Lomitapide—Feeling abnormal—Dactinomycin—testicular cancer	0.000701	0.00225	CcSEcCtD
Lomitapide—Nausea—Chlorambucil—testicular cancer	0.0007	0.00224	CcSEcCtD
Lomitapide—Paraesthesia—Ifosfamide—testicular cancer	0.0007	0.00224	CcSEcCtD
Lomitapide—Ill-defined disorder—Etoposide—testicular cancer	0.0007	0.00224	CcSEcCtD
Lomitapide—Anaemia—Etoposide—testicular cancer	0.000697	0.00223	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000696	0.00223	CcSEcCtD
Lomitapide—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000696	0.00223	CcSEcCtD
Lomitapide—Somnolence—Ifosfamide—testicular cancer	0.000693	0.00222	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—testicular cancer	0.000693	0.00222	CcSEcCtD
Lomitapide—Discomfort—Cisplatin—testicular cancer	0.000693	0.00222	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—testicular cancer	0.000691	0.00222	CcSEcCtD
Lomitapide—Migraine—Epirubicin—testicular cancer	0.000691	0.00221	CcSEcCtD
Lomitapide—Vomiting—Vinblastine—testicular cancer	0.000687	0.0022	CcSEcCtD
Lomitapide—Malaise—Etoposide—testicular cancer	0.00068	0.00218	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—testicular cancer	0.00068	0.00218	CcSEcCtD
Lomitapide—Vertigo—Etoposide—testicular cancer	0.000678	0.00217	CcSEcCtD
Lomitapide—Decreased appetite—Ifosfamide—testicular cancer	0.000678	0.00217	CcSEcCtD
Lomitapide—Headache—Vinblastine—testicular cancer	0.000676	0.00217	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000673	0.00216	CcSEcCtD
Lomitapide—Abdominal pain—Dactinomycin—testicular cancer	0.000672	0.00215	CcSEcCtD
Lomitapide—Body temperature increased—Dactinomycin—testicular cancer	0.000672	0.00215	CcSEcCtD
Lomitapide—Fatigue—Ifosfamide—testicular cancer	0.000672	0.00215	CcSEcCtD
Lomitapide—Infection—Cisplatin—testicular cancer	0.000668	0.00214	CcSEcCtD
Lomitapide—Constipation—Ifosfamide—testicular cancer	0.000667	0.00214	CcSEcCtD
Lomitapide—ABCB1—testis—testicular cancer	0.000667	0.018	CbGeAlD
Lomitapide—Nervous system disorder—Cisplatin—testicular cancer	0.000659	0.00211	CcSEcCtD
Lomitapide—Asthenia—Bleomycin—testicular cancer	0.000654	0.0021	CcSEcCtD
Lomitapide—Dehydration—Epirubicin—testicular cancer	0.000653	0.00209	CcSEcCtD
Lomitapide—Skin disorder—Cisplatin—testicular cancer	0.000653	0.00209	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—testicular cancer	0.00065	0.00208	CcSEcCtD
Lomitapide—Hyperhidrosis—Cisplatin—testicular cancer	0.00065	0.00208	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—testicular cancer	0.000648	0.00208	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—testicular cancer	0.000644	0.00206	CcSEcCtD
Lomitapide—Feeling abnormal—Ifosfamide—testicular cancer	0.000642	0.00206	CcSEcCtD
Lomitapide—Chest pain—Etoposide—testicular cancer	0.000642	0.00206	CcSEcCtD
Lomitapide—Nausea—Vinblastine—testicular cancer	0.000641	0.00205	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—testicular cancer	0.000641	0.00205	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—testicular cancer	0.000639	0.00205	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000638	0.00204	CcSEcCtD
Lomitapide—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000637	0.00204	CcSEcCtD
Lomitapide—Discomfort—Etoposide—testicular cancer	0.000634	0.00203	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—testicular cancer	0.000632	0.00203	CcSEcCtD
Lomitapide—Nasopharyngitis—Epirubicin—testicular cancer	0.000628	0.00201	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—testicular cancer	0.000622	0.00199	CcSEcCtD
Lomitapide—Gastritis—Epirubicin—testicular cancer	0.000621	0.00199	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000619	0.00198	CcSEcCtD
Lomitapide—Abdominal pain—Ifosfamide—testicular cancer	0.000616	0.00197	CcSEcCtD
Lomitapide—Body temperature increased—Ifosfamide—testicular cancer	0.000616	0.00197	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000612	0.00196	CcSEcCtD
Lomitapide—Infection—Etoposide—testicular cancer	0.000612	0.00196	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—testicular cancer	0.000611	0.00196	CcSEcCtD
Lomitapide—Asthenia—Dactinomycin—testicular cancer	0.00061	0.00196	CcSEcCtD
Lomitapide—Influenza—Epirubicin—testicular cancer	0.000607	0.00194	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—testicular cancer	0.000604	0.00194	CcSEcCtD
Lomitapide—Paraesthesia—Cisplatin—testicular cancer	0.000603	0.00193	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—testicular cancer	0.0006	0.00192	CcSEcCtD
Lomitapide—Skin disorder—Etoposide—testicular cancer	0.000598	0.00192	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—testicular cancer	0.000595	0.00191	CcSEcCtD
Lomitapide—Hyperhidrosis—Etoposide—testicular cancer	0.000595	0.00191	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—testicular cancer	0.000593	0.0019	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—testicular cancer	0.000591	0.00189	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	0.000585	0.00187	CcSEcCtD
Lomitapide—Decreased appetite—Cisplatin—testicular cancer	0.000584	0.00187	CcSEcCtD
Lomitapide—Diarrhoea—Dactinomycin—testicular cancer	0.000582	0.00186	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—testicular cancer	0.000581	0.00186	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00058	0.00186	CcSEcCtD
Lomitapide—Vomiting—Bleomycin—testicular cancer	0.00058	0.00186	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—testicular cancer	0.000578	0.00185	CcSEcCtD
Lomitapide—Infestation—Methotrexate—testicular cancer	0.000578	0.00185	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—testicular cancer	0.000575	0.00184	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000573	0.00184	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—testicular cancer	0.000565	0.00181	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—testicular cancer	0.000561	0.0018	CcSEcCtD
Lomitapide—Asthenia—Ifosfamide—testicular cancer	0.000559	0.00179	CcSEcCtD
Lomitapide—Feeling abnormal—Cisplatin—testicular cancer	0.000554	0.00177	CcSEcCtD
Lomitapide—Paraesthesia—Etoposide—testicular cancer	0.000553	0.00177	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—testicular cancer	0.000551	0.00177	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—testicular cancer	0.000549	0.00176	CcSEcCtD
Lomitapide—Somnolence—Etoposide—testicular cancer	0.000547	0.00175	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—testicular cancer	0.000547	0.00175	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—testicular cancer	0.000547	0.00175	CcSEcCtD
Lomitapide—Nausea—Bleomycin—testicular cancer	0.000542	0.00174	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—testicular cancer	0.000541	0.00173	CcSEcCtD
Lomitapide—Infestation—Epirubicin—testicular cancer	0.000541	0.00173	CcSEcCtD
Lomitapide—Vomiting—Dactinomycin—testicular cancer	0.000541	0.00173	CcSEcCtD
Lomitapide—Decreased appetite—Etoposide—testicular cancer	0.000535	0.00171	CcSEcCtD
Lomitapide—Diarrhoea—Ifosfamide—testicular cancer	0.000533	0.00171	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Etoposide—testicular cancer	0.000531	0.0017	CcSEcCtD
Lomitapide—Body temperature increased—Cisplatin—testicular cancer	0.000531	0.0017	CcSEcCtD
Lomitapide—Fatigue—Etoposide—testicular cancer	0.000531	0.0017	CcSEcCtD
Lomitapide—Constipation—Etoposide—testicular cancer	0.000526	0.00169	CcSEcCtD
Lomitapide—Haematuria—Epirubicin—testicular cancer	0.000516	0.00165	CcSEcCtD
Lomitapide—Dizziness—Ifosfamide—testicular cancer	0.000515	0.00165	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—testicular cancer	0.000513	0.00164	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—testicular cancer	0.000512	0.00164	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—testicular cancer	0.000509	0.00163	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—testicular cancer	0.000508	0.00163	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—testicular cancer	0.000508	0.00163	CcSEcCtD
Lomitapide—Feeling abnormal—Etoposide—testicular cancer	0.000507	0.00163	CcSEcCtD
Lomitapide—Nausea—Dactinomycin—testicular cancer	0.000505	0.00162	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—testicular cancer	0.000503	0.00161	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—testicular cancer	0.000501	0.0016	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—testicular cancer	0.000501	0.0016	CcSEcCtD
Lomitapide—Vomiting—Ifosfamide—testicular cancer	0.000496	0.00159	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—testicular cancer	0.000487	0.00156	CcSEcCtD
Lomitapide—Body temperature increased—Etoposide—testicular cancer	0.000487	0.00156	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—testicular cancer	0.000485	0.00155	CcSEcCtD
Lomitapide—ABCB1—lymph node—testicular cancer	0.000483	0.0131	CbGeAlD
Lomitapide—Asthenia—Cisplatin—testicular cancer	0.000482	0.00154	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—testicular cancer	0.000482	0.00154	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—testicular cancer	0.00048	0.00154	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—testicular cancer	0.000477	0.00153	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—testicular cancer	0.000477	0.00153	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—testicular cancer	0.000476	0.00153	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000473	0.00152	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—testicular cancer	0.00047	0.0015	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—testicular cancer	0.000468	0.0015	CcSEcCtD
Lomitapide—Chills—Methotrexate—testicular cancer	0.000466	0.00149	CcSEcCtD
Lomitapide—Nausea—Ifosfamide—testicular cancer	0.000463	0.00148	CcSEcCtD
Lomitapide—Diarrhoea—Cisplatin—testicular cancer	0.00046	0.00147	CcSEcCtD
Lomitapide—Eye disorder—Epirubicin—testicular cancer	0.000454	0.00145	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—testicular cancer	0.000452	0.00145	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—testicular cancer	0.000451	0.00144	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—testicular cancer	0.000444	0.00142	CcSEcCtD
Lomitapide—Asthenia—Etoposide—testicular cancer	0.000442	0.00142	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—testicular cancer	0.000442	0.00141	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—testicular cancer	0.000441	0.00141	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—testicular cancer	0.000438	0.0014	CcSEcCtD
Lomitapide—Back pain—Methotrexate—testicular cancer	0.000437	0.0014	CcSEcCtD
Lomitapide—Chills—Epirubicin—testicular cancer	0.000436	0.0014	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—testicular cancer	0.000427	0.00137	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—testicular cancer	0.000423	0.00135	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—testicular cancer	0.000421	0.00135	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—testicular cancer	0.00042	0.00135	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—testicular cancer	0.000419	0.00134	CcSEcCtD
Lomitapide—Anaemia—Methotrexate—testicular cancer	0.000418	0.00134	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—testicular cancer	0.000417	0.00134	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—testicular cancer	0.000417	0.00133	CcSEcCtD
Lomitapide—Back pain—Epirubicin—testicular cancer	0.000409	0.00131	CcSEcCtD
Lomitapide—Malaise—Methotrexate—testicular cancer	0.000407	0.00131	CcSEcCtD
Lomitapide—Dizziness—Etoposide—testicular cancer	0.000407	0.0013	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—testicular cancer	0.000406	0.0013	CcSEcCtD
Lomitapide—Vertigo—Methotrexate—testicular cancer	0.000406	0.0013	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—testicular cancer	0.000405	0.0013	CcSEcCtD
Lomitapide—Chills—Doxorubicin—testicular cancer	0.000403	0.00129	CcSEcCtD
Lomitapide—Nausea—Cisplatin—testicular cancer	0.000399	0.00128	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—testicular cancer	0.000392	0.00126	CcSEcCtD
Lomitapide—Vomiting—Etoposide—testicular cancer	0.000391	0.00125	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—testicular cancer	0.000391	0.00125	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—testicular cancer	0.000391	0.00125	CcSEcCtD
Lomitapide—Headache—Etoposide—testicular cancer	0.000386	0.00124	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—testicular cancer	0.000385	0.00124	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—testicular cancer	0.000385	0.00123	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—testicular cancer	0.000385	0.00123	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—testicular cancer	0.000385	0.00123	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000382	0.00122	CcSEcCtD
Lomitapide—Malaise—Epirubicin—testicular cancer	0.000381	0.00122	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—testicular cancer	0.00038	0.00122	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—testicular cancer	0.00038	0.00122	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—testicular cancer	0.000378	0.00121	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—testicular cancer	0.000376	0.00121	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—testicular cancer	0.000374	0.0012	CcSEcCtD
Lomitapide—Infection—Methotrexate—testicular cancer	0.000366	0.00117	CcSEcCtD
Lomitapide—Nausea—Etoposide—testicular cancer	0.000366	0.00117	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—testicular cancer	0.000363	0.00116	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—testicular cancer	0.000362	0.00116	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—testicular cancer	0.000362	0.00116	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—testicular cancer	0.00036	0.00115	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—testicular cancer	0.00036	0.00115	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—testicular cancer	0.00036	0.00115	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—testicular cancer	0.000358	0.00115	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000357	0.00115	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—testicular cancer	0.000356	0.00114	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—testicular cancer	0.000356	0.00114	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—testicular cancer	0.000353	0.00113	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—testicular cancer	0.000352	0.00113	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—testicular cancer	0.000351	0.00113	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—testicular cancer	0.000346	0.00111	CcSEcCtD
Lomitapide—Infection—Epirubicin—testicular cancer	0.000343	0.0011	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—testicular cancer	0.000338	0.00108	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000336	0.00108	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—testicular cancer	0.000335	0.00107	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—testicular cancer	0.000334	0.00107	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—testicular cancer	0.000333	0.00107	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—testicular cancer	0.000333	0.00107	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—testicular cancer	0.000333	0.00107	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—testicular cancer	0.000331	0.00106	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000331	0.00106	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—testicular cancer	0.000329	0.00105	CcSEcCtD
Lomitapide—Somnolence—Methotrexate—testicular cancer	0.000328	0.00105	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—testicular cancer	0.000326	0.00104	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—testicular cancer	0.000325	0.00104	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—testicular cancer	0.000321	0.00103	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000318	0.00102	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—testicular cancer	0.000318	0.00102	CcSEcCtD
Lomitapide—Infection—Doxorubicin—testicular cancer	0.000317	0.00102	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000314	0.00101	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—testicular cancer	0.000313	0.001	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—testicular cancer	0.00031	0.000994	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—testicular cancer	0.00031	0.000993	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—testicular cancer	0.000309	0.000989	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—testicular cancer	0.000307	0.000983	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—testicular cancer	0.000304	0.000973	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—testicular cancer	0.000304	0.000973	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—testicular cancer	0.000302	0.000966	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—testicular cancer	0.0003	0.000961	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000298	0.000954	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—testicular cancer	0.000297	0.000953	CcSEcCtD
Lomitapide—Constipation—Epirubicin—testicular cancer	0.000295	0.000945	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—testicular cancer	0.000291	0.000934	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—testicular cancer	0.000291	0.000934	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000291	0.000932	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—testicular cancer	0.000287	0.000919	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—testicular cancer	0.000284	0.000911	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—testicular cancer	0.000284	0.000909	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—testicular cancer	0.000282	0.000904	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—testicular cancer	0.000281	0.0009	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—testicular cancer	0.000278	0.000889	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000276	0.000883	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—testicular cancer	0.000275	0.000882	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—testicular cancer	0.000273	0.000875	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—testicular cancer	0.000273	0.000874	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—testicular cancer	0.000273	0.000874	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—testicular cancer	0.000265	0.000848	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—testicular cancer	0.000263	0.000843	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000261	0.000836	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—testicular cancer	0.000252	0.000809	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—testicular cancer	0.000252	0.000809	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—testicular cancer	0.000252	0.000808	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—testicular cancer	0.000248	0.000793	CcSEcCtD
Lomitapide—Dizziness—Methotrexate—testicular cancer	0.000244	0.000781	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—testicular cancer	0.000236	0.000756	CcSEcCtD
Lomitapide—Vomiting—Methotrexate—testicular cancer	0.000234	0.000751	CcSEcCtD
Lomitapide—Headache—Methotrexate—testicular cancer	0.000231	0.00074	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—testicular cancer	0.000229	0.000734	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—testicular cancer	0.000228	0.000731	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—testicular cancer	0.000219	0.000703	CcSEcCtD
Lomitapide—Nausea—Methotrexate—testicular cancer	0.000219	0.000702	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—testicular cancer	0.000218	0.0007	CcSEcCtD
Lomitapide—Headache—Epirubicin—testicular cancer	0.000216	0.000693	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—testicular cancer	0.000211	0.000676	CcSEcCtD
Lomitapide—Nausea—Epirubicin—testicular cancer	0.000205	0.000657	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—testicular cancer	0.000203	0.00065	CcSEcCtD
Lomitapide—Headache—Doxorubicin—testicular cancer	0.0002	0.000641	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—testicular cancer	0.00019	0.000608	CcSEcCtD
